US Piriformis Syndrome Market Research Report By Cause (Trauma, Spasms, Others) - Forecast to 2035

US Piriformis Syndrome Market Overview

As per MRFR analysis, the US Piriformis Syndrome Market Size was estimated at 38.57 (USD Million) in 2023. The US Piriformis Syndrome Market Industry is expected to grow from 41.5(USD Million) in 2024 to 73 (USD Million) by 2035. The US Piriformis Syndrome Market CAGR (growth rate) is expected to be around 5.268% during the forecast period (2025 - 2035).

Key US Piriformis Syndrome Market Trends Highlighted

The US Piriformis Syndrome Market is witnessing significant trends driven by an increasing prevalence of this neuromuscular condition. Growing awareness about this syndrome among healthcare professionals and patients is a key driver. Initiatives aimed at educating both neurologists and physiotherapists about effective diagnosis and treatment options are on the rise, leading to improved patient outcomes and greater access to specialized care.

Additionally, the national focus on pain management has resulted in more patients being diagnosed, as the healthcare system recognizes the need for addressing chronic pain conditions. There are notable opportunities within the US market that can be explored, particularly in the realm of advanced treatment modalities. Non-invasive therapies such as physical therapy and acupuncture are gaining traction as patients seek alternatives to surgery.

Furthermore, an increase in research funding for alternative treatments, driven by a broader acceptance of complementary medicine, stands to benefit individuals suffering from Piriformis Syndrome. The integration of telehealth services also presents a chance to reach more patients in remote areas, enhancing accessibility to expert care. Recent times have seen a growing trend of personalized medicine in the US healthcare landscape.

After realizing that one-size-fits-all approaches do not deliver optimal results, medical professionals are focusing on tailoring treatment plans based on the specific needs of the individual. This shift toward personalized approaches, combined with the development of new technologies for better diagnosis and treatment options, positions the US Piriformis Syndrome Market for focused growth. As healthcare policies continue to evolve and more emphasis is placed on holistic treatment, the market is likely to undergo further innovations and positive development.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Piriformis Syndrome Market Drivers

Increasing Awareness and Diagnosis of Piriformis Syndrome

In the United States, there has been a notable increase in awareness and diagnosis of Piriformis Syndrome, leading to more patients seeking treatment. According to the American Academy of Orthopaedic Surgeons, the understanding of musculoskeletal disorders has improved significantly over the past decade. This increase in awareness can be linked to educational programs and diagnostic advancements introduced by organizations like the American Physical Therapy Association, which reported that musculoskeletal pain affects over 50% of adults in the US at some point in their lives.

This growing recognition of Piriformis Syndrome has led to increased patient referrals, contributing to the growth of the US Piriformis Syndrome Market Industry as healthcare providers are now more capable of diagnosing patients accurately. Consequently, as more patients are identified and treated, demand for specific therapies related to Piriformis Syndrome treatment continues to rise.

Growth in Physical Therapy and Non-invasive Treatment Options

There is a significant increase in the adoption of physical therapy and non-invasive treatment options for managing Piriformis Syndrome in the United States. The Bureau of Labor Statistics projects that the employment of physical therapists will grow by 22% from 2020 to 2030, much faster than the average for all occupations. This surge in job growth indicates a broader acceptance and utilization of physical therapy services as a primary treatment modality, which can help alleviate symptoms of Piriformis Syndrome.

With organizations like the American Physical Therapy Association promoting evidence-based practice, patients are becoming more aware of the efficacy of physical therapy, driving growth in the US Piriformis Syndrome Market Industry. Non-invasive treatments such as stretching, strengthening exercises, and manual therapy have also gained traction, leading to a healthier population and reduced reliance on surgical interventions.

Increased Prevalence of Sedentary Lifestyles

The prevalence of sedentary lifestyles in the United States has led to an increase in musculoskeletal disorders, including Piriformis Syndrome. According to the Centers for Disease Control and Prevention, over 80% of US adults do not meet the recommended guidelines for physical activity. This trend of prolonged sitting and lack of movement has resulted in a higher incidence of conditions like Piriformis Syndrome.

Consequently, healthcare providers are witnessing more cases, resulting in a growing demand for specialized treatments, thus driving the US Piriformis Syndrome Market Industry. With the increasing focus on workplace ergonomics and wellness programs, more individuals are recognizing the importance of addressing musculoskeletal health, further contributing to market growth.

US Piriformis Syndrome Market Segment Insights

Piriformis Syndrome Market Cause Insights

The US Piriformis Syndrome Market is significantly influenced by the underlying causes of the condition, which can be classified into categories such as Trauma, Spasms, and Others. Trauma plays a crucial role in the onset of Piriformis Syndrome, as injuries from accidents or sports can lead to inflammation or irritation of the piriformis muscle, often resulting in nerve compression. This category is critical because the impact of trauma-related causes can be substantial, leading to both acute and chronic pain, which contributes to the prevalence of this syndrome in the United States.

Spasms, another prominent cause, occur when the piriformis muscle tightens involuntarily. This tightening can lead to pain that radiates down the leg, mimicking sciatica. The prevalence of muscle spasms is significant among patients who engage in repetitive activities or maintain poor posture, making it an area of concern for various occupational health environments in the US. The awareness of these spasms is important for the development of targeted therapies and rehabilitation approaches.

The "Others" category encompasses a range of potential causes, such as anatomical variations, overuse injuries, and other underlying health conditions. These broader causes expand the understanding of the syndrome's complexity and highlight the need for a multifaceted approach to diagnosis and treatment. This diversity within the market segmentation allows healthcare providers to tailor individual treatment regimens, ultimately offering a more personalized healthcare experience.

The complexity of Piriformis Syndrome driven by these causes emphasizes the potential for growth in the US Piriformis Syndrome Market. As medical practitioners and researchers continue to explore the mechanisms behind trauma and muscle spasms, they will likely develop innovative treatment options and therapy methods. Furthermore, the growing awareness among patients regarding the impact of lifestyle factors on muscle health underlines the market's potential to expand in preventive healthcare solutions. The interplay of these causes contributes to the broader dynamics of market growth, influenced by both innovations in treatment and an increasing demand for effective care.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Piriformis Syndrome Market Key Players and Competitive Insights

The US Piriformis Syndrome Market is characterized by a competitive landscape that includes several key players and a variety of treatment options aimed at alleviating the condition's symptoms, which are often debilitating for affected individuals. Piriformis syndrome occurs when the piriformis muscle compresses the sciatic nerve, leading to pain and discomfort. The treatments in this market range from physical therapy and medication to surgical interventions, each catering to different severity levels of the syndrome.

As a result, competition within the market has intensified, with companies striving to innovate and differentiate their offerings, all while addressing the growing need for effective solutions. Insights into the competitive dynamics reveal particular strengths, market strategies, and geographical emphases employed by leading firms in the sector. Teleflex has carved a niche within the US Piriformis Syndrome market through its robust product offerings that primarily focus on minimally invasive surgical solutions and advanced medical devices.

The company's commitment to innovation is evident in its development of specialized instruments designed to facilitate effective treatment through less invasive means, thereby enhancing patient recovery times and outcomes. Furthermore, Teleflex's strong distribution channels and partnerships with healthcare providers bolster its presence in the market. Their ability to swiftly adapt to technological advancements and clinical feedback allows Teleflex to maintain its competitive edge, ensuring they cater specifically to the needs of practitioners and patients dealing with piriformis syndrome.

Smith and Nephew represents another formidable player in the US Piriformis Syndrome market, offering a wide range of products, particularly in orthopedic solutions and rehabilitation technologies. The company's strength lies in its ability to provide comprehensive treatment options designed to alleviate the symptoms associated with piriformis syndrome, including surgical solutions and post-operative care products. Smith and Nephew’s commitment to research and development has led to successful innovation and the introduction of new technologies aimed at improving patient outcomes. 

Additionally, strategic mergers and acquisitions have enhanced their market position, allowing them to expand their product portfolio and distribution networks within the US. With a focus on advanced surgical techniques and effective rehabilitation products, Smith and Nephew continues to assert its dominance in addressing the challenges presented by piriformis syndrome.

Key Companies in the US Piriformis Syndrome Market Include

• Teleflex


• Smith and Nephew


• Amedica Corporation


• Zyga Technology


• Medtronic


• Boston Scientific


• Abbott Laboratories


• Horizon Therapeutics


• Aesculap


• Stryker


• NuVasive


• Orthofix Medical


• Johnson and Johnson


• Cynosure


• B. Braun Melsungen AG

US Piriformis Syndrome Market Industry Developments

The US Piriformis Syndrome Market has seen notable developments in recent months, focusing on growth and innovation from key players such as Teleflex, Smith and Nephew, Amedica Corporation, and Medtronic. In particular, there's been increasing interest in minimally invasive procedures and advancements in treatment solutions aimed at alleviating the symptoms of piriformis syndrome. Current affairs highlight a rise in the market valuation of companies like Boston Scientific and Abbott Laboratories, reflecting their commitment to Research and Development, which is positively impacting patient outcomes.

In September 2023, Johnson and Johnson announced a strategic partnership with Aesculap to enhance the availability of their products targeted at treating musculoskeletal disorders, further solidifying their presence in this niche market. Moreover, the ongoing regulatory approvals for innovative devices and medications signify a robust growth trajectory. In the last couple of years, improvements in reimbursement policies for treatment options have played a crucial role in market expansion, driving competitive dynamics among companies like Stryker and NuVasive. Overall, the market's landscape is evolving, supported by technological advancements and strategic collaborations among leading entities.

US Piriformis Syndrome Market Segmentation Insights

Piriformis Syndrome Market Cause Outlook

• Trauma


• Spasms


• Others

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	38.57(USD Million)
MARKET SIZE 2024	41.5(USD Million)
MARKET SIZE 2035	73.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.268% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Teleflex, Smith and Nephew, Amedica Corporation, Zyga Technology, Medtronic, Boston Scientific, Abbott Laboratories, Horizon Therapeutics, Aesculap, Stryker, NuVasive, Orthofix Medical, Johnson and Johnson, Cynosure, B. Braun Melsungen AG
SEGMENTS COVERED	Cause
KEY MARKET OPPORTUNITIES	Increased awareness campaigns, Non-invasive treatment options, Digital health solutions, Rehabilitation service expansion, Targeted pain management products
KEY MARKET DYNAMICS	Rising awareness of treatment options, Increasing prevalence of sciatica cases, Growth in physical therapy services, Advancements in diagnostic technologies, Expanding healthcare infrastructure
COUNTRIES COVERED	US